-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics: Q4 Earnings Insights

Benzinga·03/04/2026 21:18:29
Listen to the news

The Q4 earnings report for Keros Therapeutics (NASDAQ:KROS) was released on Wednesday, March 4, 2026 at 04:01 PM.

Here's what investors need to know about the latest announcement.

Earnings

Keros Therapeutics missed estimated earnings by -82.98%, reporting an EPS of $-0.86 versus an estimate of $-0.47.

Revenue was down $2.66 million from the same period last year.

Earnings History Overview

Last quarter the company beat on EPS by $0.82 which was followed by a 3.32% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Keros Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.